Erigeron Breviscapus Prevents Defective Endothelium-Dependent Relaxation in Diabetic Rat Aorta

BH Zhu,YY Guan,H He,MJ Lin
DOI: https://doi.org/10.1016/s0024-3205(99)00400-2
IF: 6.78
1999-01-01
Life Sciences
Abstract:We examined the endothelium-dependent relaxation response to acetylcholine (Ach) in streptozotocin-induced diabetic rat aorta at the stages of 2- and 6-wks' duration in vitro, and compared with another two groups which were treated with dietary supplement of 0.1% Aminoquanidine (AG) and 0.5% Erigeron breviscapus(EB) from 1-week of diabetes induction. At the stage of 2-wks' duration of diabetes, relaxation responses to lower concentrations of Ach in 0.3uM phenylepherine-precontracted aortas were diminished significantly (P < 0.05) compared with age-matched control, but the maximal relaxation of Ach remained unchanged. At the stage of 6-wks' duration, diabetes caused an approximately 60% (P < 0.001) deficit in maximum relaxation, and this was significantly (P < 0.001) prevented in AG and EB treated groups. There was an approximately 40% enhancement in the maximum contractile response to phenylepherine with diabetes (P < 0.05), which was unaffected significantly by AG and EB treatments. The data suggest that the defective endothelium-dependent relaxation in diabetic rat aorta occurred as early as 2-wks' duration of diabetes, and the treatments of AG and EB could protect vascular endothelium although the deficits in vascular smooth muscle contractile responses were not protected.
What problem does this paper attempt to address?